Lin‐Chau Chang

808 total citations
30 papers, 634 citations indexed

About

Lin‐Chau Chang is a scholar working on Molecular Biology, Economics and Econometrics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Lin‐Chau Chang has authored 30 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Economics and Econometrics and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Lin‐Chau Chang's work include Pharmaceutical Economics and Policy (7 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Pharmaceutical studies and practices (5 papers). Lin‐Chau Chang is often cited by papers focused on Pharmaceutical Economics and Policy (7 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Pharmaceutical studies and practices (5 papers). Lin‐Chau Chang collaborates with scholars based in Taiwan and United States. Lin‐Chau Chang's co-authors include Churn‐Shiouh Gau, Huan‐Tsung Chang, Shao‐Wen Sun, Cheng‐Kang Chiang, Tai‐Chia Chiu, Ching‐Hua Kuo, Kuo‐Chin Huang, Wei‐Shiung Yang, Chi‐Ling Chen and Wei‐Kai Wu and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Journal of Colloid and Interface Science.

In The Last Decade

Lin‐Chau Chang

30 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin‐Chau Chang Taiwan 12 201 115 103 94 65 30 634
Robert A. Carr United States 19 193 1.0× 128 1.1× 41 0.4× 67 0.7× 30 0.5× 41 986
John Ho Hong Kong 15 358 1.8× 41 0.4× 29 0.3× 52 0.6× 81 1.2× 57 822
Mario Eandi Italy 18 199 1.0× 86 0.7× 69 0.7× 49 0.5× 62 1.0× 55 879
Maria Constantinou United States 13 256 1.3× 44 0.4× 54 0.5× 38 0.4× 48 0.7× 40 780
Ren-ai Xu China 16 258 1.3× 89 0.8× 26 0.3× 41 0.4× 32 0.5× 93 878
Sicheng Liang China 16 382 1.9× 88 0.8× 36 0.3× 44 0.5× 22 0.3× 53 801
Nelci F. Höehr Brazil 18 171 0.9× 201 1.7× 48 0.5× 11 0.1× 91 1.4× 35 828
R. Obach Spain 19 217 1.1× 119 1.0× 39 0.4× 150 1.6× 113 1.7× 60 1.1k
Hina Shamshad Pakistan 11 344 1.7× 74 0.6× 65 0.6× 79 0.8× 64 1.0× 32 776

Countries citing papers authored by Lin‐Chau Chang

Since Specialization
Citations

This map shows the geographic impact of Lin‐Chau Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin‐Chau Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin‐Chau Chang more than expected).

Fields of papers citing papers by Lin‐Chau Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin‐Chau Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin‐Chau Chang. The network helps show where Lin‐Chau Chang may publish in the future.

Co-authorship network of co-authors of Lin‐Chau Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Lin‐Chau Chang. A scholar is included among the top collaborators of Lin‐Chau Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin‐Chau Chang. Lin‐Chau Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Jolie L., et al.. (2025). Indocyanine green-mediated photothermal release of lidocaine from genipin-crosslinked gelatin hydrogel in nerve block. International Journal of Biological Macromolecules. 297. 139518–139518. 2 indexed citations
2.
Weng, Chen, Joanna Dong, Shang‐Hung Lin, et al.. (2025). Analysis of cellular and gene therapy product reviews in the United States. Regulatory Toxicology and Pharmacology. 162. 105885–105885. 1 indexed citations
3.
Chiang, Yi‐Hsuan, Yee‐Chun Chen, Yijing Chen, et al.. (2023). Enhancing the identification of voriconazole-associated hepatotoxicity by targeted metabolomics. International Journal of Antimicrobial Agents. 63(1). 107028–107028. 5 indexed citations
4.
Lin, Chin‐Jung, et al.. (2023). Curcumin-derived carbon quantum dots: Dual actions in mitigating tau hyperphosphorylation and amyloid beta aggregation. Colloids and Surfaces B Biointerfaces. 234. 113676–113676. 18 indexed citations
5.
Liu, Yu‐Hsuan, et al.. (2023). Regulatory considerations for generic products of non-biological complex drugs. Journal of Food and Drug Analysis. 31(1). 20–31. 6 indexed citations
6.
Huang, Yujun, et al.. (2022). Orphan drug development: The impact of regulatory and reimbursement frameworks. Drug Discovery Today. 27(6). 1724–1732. 6 indexed citations
7.
8.
Chang, Lin‐Chau. (2019). The biosimilar pathway in the USA: An analysis of the innovator company and biosimilar company perspectives and beyond. Journal of Food and Drug Analysis. 27(3). 671–678. 5 indexed citations
9.
Chang, Lin‐Chau, Chih‐Fen Huang, Mei‐Shu Lai, et al.. (2018). Prognostic factors in epithelial ovarian cancer: A population-based study. PLoS ONE. 13(3). e0194993–e0194993. 69 indexed citations
10.
Chang, Lin‐Chau, et al.. (2018). Identification of factors associated with first-cycle drug approval rates and regulatory outcomes for new drug applications. Pharmacological Research. 139. 166–172. 1 indexed citations
11.
12.
Chang, Lin‐Chau, Jaw‐Jou Kang, & Churn‐Shiouh Gau. (2016). Development of the risk-based, phased-in approach for the international harmonization of the regulation of container closure systems for drugs in Taiwan. Regulatory Toxicology and Pharmacology. 77. 252–256. 2 indexed citations
13.
Chang, Lin‐Chau, Jaw‐Jou Kang, & Churn‐Shiouh Gau. (2015). The evolution and challenges for the international harmonization of the regulation of pharmaceutical excipients in Taiwan. Regulatory Toxicology and Pharmacology. 73(3). 947–952. 4 indexed citations
14.
Chang, Lin‐Chau & Churn‐Shiouh Gau. (2013). Statistics, Quality Review Issues, and Beyond for Generic Drug Applications in Taiwan. Therapeutic Innovation & Regulatory Science. 47(6). 670–677. 4 indexed citations
15.
Chang, Lin‐Chau, Kuo‐Chin Huang, Yen‐Wen Wu, et al.. (2009). The Clinical Implications of Blood Adiponectin in Cardiometabolic Disorders. Journal of the Formosan Medical Association. 108(5). 353–366. 46 indexed citations
16.
Lu, Jin‐Ying, Kuo‐Chin Huang, Lin‐Chau Chang, et al.. (2008). Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond. Journal of Biomedical Science. 15(5). 565–576. 81 indexed citations
17.
Chang, Lin‐Chau, et al.. (2008). Interfacial properties of Pluronics and the interactions between Pluronics and cholesterol/DPPC mixed monolayers. Journal of Colloid and Interface Science. 322(1). 263–273. 40 indexed citations
18.
Chang, Lin‐Chau, Huan‐Tsung Chang, & Shao‐Wen Sun. (2006). Cyclodextrin-modified microemulsion electrokinetic chromatography for separation of α-, γ-, δ-tocopherol and α-tocopherol acetate. Journal of Chromatography A. 1110(1-2). 227–234. 22 indexed citations
19.
Chang, Lin‐Chau & Shao‐Wen Sun. (2005). Micellar electrokinetic chromatography for separation of a mixture of coptis alkaloids, scute flavonoids, and rhubarb anthraquinones and bianthrones. Journal of Pharmaceutical and Biomedical Analysis. 40(1). 62–67. 29 indexed citations
20.
Chang, Lin‐Chau, et al.. (2005). Interactions of Pluronics with phospholipid monolayers at the air–water interface. Journal of Colloid and Interface Science. 285(2). 640–652. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert A. Carr Breakdown of academic impact, for papers by John Ho Breakdown of academic impact, for papers by Mario Eandi Breakdown of academic impact, for papers by Maria Constantinou Breakdown of academic impact, for papers by Ren-ai Xu Breakdown of academic impact, for papers by Sicheng Liang Breakdown of academic impact, for papers by Nelci F. Höehr Breakdown of academic impact, for papers by R. Obach Breakdown of academic impact, for papers by Hina Shamshad
Rankless by CCL
2026